Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness

W. Paul Duprex, Rebecca Ellis Dutch

Producción científica: Articlerevisión exhaustiva

19 Citas (Scopus)

Resumen

The Paramyxoviridae family includes established human pathogens such as measles virus, mumps virus, and the human parainfluenza viruses; highly lethal zoonotic pathogens such as Nipah virus; and a number of recently identified agents, such as Sosuga virus, which remain poorly understood. The high human-to-human transmission rate of paramyxoviruses such as measles virus, high case fatality rate associated with other family members such as Nipah virus, and the existence of poorly characterized zoonotic pathogens raise concern that known and unknown paramyxoviruses have significant pandemic potential. In this review, the general life cycle, taxonomic relationships, and viral pathogenesis are described for paramyxoviruses that cause both systemic and respiratory system-restricted infections. Next, key gaps in critical areas are presented, following detailed conversations with subject matter experts and based on the current literature. Finally, we present an assessment of potential prototype pathogen candidates that could be used as models to study this important virus family, including assessment of the strengths and weaknesses of each potential prototype.

Idioma originalEnglish
Páginas (desde-hasta)S390-S397
PublicaciónJournal of Infectious Diseases
Volumen228
DOI
EstadoPublished - oct 15 2023

Nota bibliográfica

Publisher Copyright:
© 2023 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved.

Financiación

Financial support. This work was supported by the National Institutes of Health (grant numbers 5R01 AI40758 and 1R01 AI051517 to R. E. D.) and the Coalition for Epidemic Preparedness Innovations and the Henry Hillman Family Foundation (to W. P. D.). Supplement sponsorship. This article appears as part of the supplement “Pandemic Preparedness at NIAID: Prototype Pathogen Approach to Accelerate Medical Countermeasures—Vaccines and Monoclonal Antibodies,” sponsored by the National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD.

FinanciadoresNúmero del financiador
Henry Hillman Family Foundation
National Institutes of Health (NIH)1R01 AI051517, 5R01 AI40758
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases
Coalition for Epidemic Preparedness Innovations

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Infectious Diseases

    Huella

    Profundice en los temas de investigación de 'Paramyxoviruses: Pathogenesis, Vaccines, Antivirals, and Prototypes for Pandemic Preparedness'. En conjunto forman una huella única.

    Citar esto